Cargando…

Morbidity and Days Alive and Out of Hospital Within 90 Days Following Radical Cystectomy for Bladder Cancer

BACKGROUND: Morbidity after radical cystectomy (RC) is usually quantified in terms of rates of complications, mortality, reoperations, and readmissions, and length of stay (LOS). The overall burden following RC within the first 90 d following RC may be better described using days alive and out of ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maibom, Sophia L., Røder, Martin A., Poulsen, Alicia M., Thind, Peter O., Salling, Marie L., Salling, Lisbeth N., Kehlet, Henrik, Brasso, Klaus, Joensen, Ulla N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Bladder Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317890/ https://www.ncbi.nlm.nih.gov/pubmed/34337519 http://dx.doi.org/10.1016/j.euros.2021.03.010

Ejemplares similares

Short-term morbidity and mortality following radical cystectomy: a systematic review
por: Maibom, Sophia Liff, et al.
Publicado: (2021)

Robot-assisted laparoscopic radical cystectomy with intracorporeal ileal conduit diversion versus open radical cystectomy with ileal conduit for bladder cancer in an ERAS setup (BORARC): protocol for a single-centre, double-blinded, randomised feasibility study
por: Maibom, Sophia Liff, et al.
Publicado: (2023)

Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer
por: Schmidt, Bogdana, et al.
Publicado: (2022)

Impact of Diagnosing Urologists and Hospitals on the Use of Radical Cystectomy
por: Golla, Vishnukamal, et al.
Publicado: (2020)

Minimum Volume Standards: An Incentive To Perform More Radical Cystectomies?
por: Nuijens, Siberyn T., et al.
Publicado: (2023)

Defining Factors Associated with High-quality Surgery Following Radical Cystectomy: Analysis of the British Association of Urological Surgeons Cystectomy Audit
por: Tan, Wei Shen, et al.
Publicado: (2021)

Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans
por: Kumar, Abhishek, et al.
Publicado: (2021)

Learning Curve Analysis for Intracorporeal Robot-assisted Radical Cystectomy: Results from the EAU Robotic Urology Section Scientific Working Group
por: Wijburg, Carl J., et al.
Publicado: (2022)

Predicting 90-day and long-term mortality in octogenarians undergoing radical cystectomy
por: Froehner, Michael, et al.
Publicado: (2018)

Updates on enhanced recovery after surgery for radical cystectomy
por: Lee, Grace, et al.
Publicado: (2022)

Potential Carbon Savings with Day-case Compared to Inpatient Transurethral Resection of Bladder Tumour Surgery in England: A Retrospective Observational Study Using Administrative Data
por: Phull, Manraj, et al.
Publicado: (2023)

The effect of preoperative clinical variables on the 30- and 90-day morbidity and mortality after radical cystectomy: A single-centre study
por: Mursi, Khaled, et al.
Publicado: (2013)

Alive another day
por: BOGDANOVIC, Nenad
Publicado: (2007)

Intensified and Standardized Digital Communication with Cystectomy Patients as a Potentially Simple and Effective Modality for Early Detection of Postoperative Complications: Results from a Pilot Study
por: Birkhäuser, Frédéric D., et al.
Publicado: (2020)

Health-related quality of life after radical cystectomy
por: Choi, Hoon, et al.
Publicado: (2020)

Enhanced recovery after surgery of patients undergoing radical cystectomy for bladder cancer
por: Sung, Luck Hee, et al.
Publicado: (2020)

Readmission Rate and Causes at 90-Day after Radical Cystectomy in Patients on Early Recovery after Surgery Protocol
por: Altobelli, Emanuela, et al.
Publicado: (2017)

Perioperative morbidity of radical cystectomy: A review
por: Kulkarni, Jagdeesh N.
Publicado: (2011)

Plasma pro-atrial natriuretic peptide to indicate fluid balance during cystectomy: a prospective observational study
por: Rasmussen, Kirsten C, et al.
Publicado: (2016)

Days alive and out of hospital after laparoscopic cholecystectomy
por: Alexander, Harry, et al.
Publicado: (2022)

High–Normal Preoperative Potassium Level Is Associated with Reduced 30–Day Morbidity and Shorter Hospital Stay after Radical Cystectomy
por: Borgmann, Hendrik, et al.
Publicado: (2022)

Utility of Patient-Reported Symptom and Functional Outcomes to Indicate Recovery after First 90 Days of Radical Cystectomy: A Longitudinal Study
por: Wang, Xin Shelley, et al.
Publicado: (2023)

Darifenacin treatment for overactive bladder in patients who expressed dissatisfaction with prior extended-release antimuscarinic therapy
por: Zinner, N, et al.
Publicado: (2008)

Trial-based Cost-effectiveness Analysis of an Immediate Postoperative Mitomycin C Instillation in Patients with Non–muscle-invasive Bladder Cancer
por: Hentschel, Anouk E., et al.
Publicado: (2022)

Association of Days Alive and at Home at Day 90 After Intensive Care Unit Admission With Long-term Survival and Functional Status Among Mechanically Ventilated Patients
por: Taran, Shaurya, et al.
Publicado: (2023)

“Alive Day is the Day”: A Qualitative Study of Experiences of Learned Helplessness in Maintenance Haemodialysis Patients
por: Xie, Chunyan, et al.
Publicado: (2023)

Early Warning Models to Predict the 90-Day Urinary Tract Infection Risk After Radical Cystectomy and Urinary Diversion for Patients With Bladder Cancer
por: Lu, Xun, et al.
Publicado: (2022)

Quality of Life in Patients with High-grade Non–muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS Trial
por: van Straten, Christine G.J.I., et al.
Publicado: (2023)

Impact of perioperative inflammation on days alive and at home after surgery
por: Kunkel, David, et al.
Publicado: (2022)

Days alive and out of hospital at 30 days and outcomes of off-pump coronary artery bypass grafting
por: Oh, Ah Ran, et al.
Publicado: (2023)

The July Effect in Radical Cystectomy: Mortality, Morbidity, and Efficiency
por: Zuk, Keegan, et al.
Publicado: (2016)

Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study
por: Choo, M-S, et al.
Publicado: (2008)

Validation and Reliability Testing of the EORTC QLQ-NMIBC24 Questionnaire Module to Assess Patient-reported Outcomes in Non–Muscle-invasive Bladder Cancer
por: Blazeby, Jane M., et al.
Publicado: (2014)

The Significant Role of Depression in Elderly Patients with Bladder Cancer
por: Oserowsky, Alexander, et al.
Publicado: (2021)

SPTAN1, APC, and FGFR3 Mutation Status and APOBEC Mutation Signatures are Predictive of Mitomycin C Response in Non-muscle-invasive Bladder Cancer
por: Lindgren, Maria Skydt, et al.
Publicado: (2021)

A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily Practice
por: de Ruiter, Ben-Max, et al.
Publicado: (2022)

Role of Serum Lymphocyte-derived Biomarkers in Nonmetastatic Muscle-invasive Bladder Cancer Patients Treated with Trimodal Therapy
por: Kool, Ronald, et al.
Publicado: (2021)

Partial Versus Complete Bacillus Calmette-Guérin Intravesical Therapy and Bladder Cancer Outcomes in High-risk Non–muscle-invasive Bladder Cancer: Is NIMBUS the Full Story?
por: Rezaee, Michael E., et al.
Publicado: (2021)

Living with Bladder Cancer: Self-reported Changes in Patients’ Functional and Overall Health Status Following Diagnosis
por: Ungerer, Garrett, et al.
Publicado: (2020)

The Use of Urine Mycobacterium tuberculosis Complex Polymerase Chain Reaction as a Predictive Factor for Recurrence and Progression After Intravesical Bacillus Calmette-Guérin Therapy in Patients with Non–muscle‑invasive Bladder Cancer
por: Muto, Satoru, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jt514kthf6k7tc6pvellasvfnn